ABBVIE LTD

Featured products of AbbVie

Rinvoq

Rinvoq PR tab 15 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Rinvoq PR tab 30 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Rinvoq PR tab 45 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Skyrizi

Skyrizi soln for inj in pre-filled pen 150 mg/1 mL

risankizumab

Packing/Price

1's

MIMS Class

Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

L04AC18 - risankizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Venclexta

Venclexta FC tab 10 mg

venetoclax

Packing/Price

14's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 100 mg

venetoclax

Packing/Price

120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 50 mg

venetoclax

Packing/Price

7's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Distributed by DKSH

Rinvoq

Rinvoq PR tab 15 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Rinvoq PR tab 30 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Rinvoq PR tab 45 mg

upadacitinib

Packing/Price

28's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.

Skyrizi

Skyrizi soln for inj in pre-filled pen 150 mg/1 mL

risankizumab

Packing/Price

1's

MIMS Class

Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

L04AC18 - risankizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Venclexta

Venclexta FC tab 10 mg

venetoclax

Packing/Price

14's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 100 mg

venetoclax

Packing/Price

120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 50 mg

venetoclax

Packing/Price

7's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Distributed by The Glory Medicina

Skyrizi

Skyrizi soln for inj in pre-filled pen 150 mg/1 mL

risankizumab

Packing/Price

1's

MIMS Class

Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

L04AC18 - risankizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Venclexta

Venclexta FC tab 10 mg

venetoclax

Packing/Price

14's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 100 mg

venetoclax

Packing/Price

120's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Venclexta FC tab 50 mg

venetoclax

Packing/Price

7's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX52 - venetoclax : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Marketer for Forest Laboratories Ireland

Aquipta

Aquipta tab 10 mg

atogepant

Packing/Price

28's

MIMS Class

Antimigraine Preparations

ATC Classification

N02CD07 - atogepant : Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.

Aquipta tab 60 mg

atogepant

Packing/Price

28's

MIMS Class

Antimigraine Preparations

ATC Classification

N02CD07 - atogepant : Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.